US FDA – URGENT/11 Cybersecurity Vulnerabilities in a Widely-Used Third-Party Software Component May Introduce Risks During Use of Certain Medical Devices
Published in Cybersecurity and United States Food and Drug Administration - US FDA
More from CybersecurityMore posts in Cybersecurity »
- EU – MDCG 2019-16 – Guidande on Cybersecurity for medical devices
- TGA presentation: Cybersecurity for medical devices
- IMDRF draft document – Principles and Practices for Medical Device Cybersecurity
- US FDA Patient Engagement Advisory Committee – Cybersecurity in Medical Devices: Communication That Empowers Patients
- TGA – Webinar: The cybersecurity of medical devices
More from United States Food and Drug Administration - US FDAMore posts in United States Food and Drug Administration - US FDA »
- EU – Team-NB Position Paper on Documentation Requirements for Drug Device Combination Products Falling in the Scope of Article 117 of MDR 2017/745.
- US – FDA Issues Immediately in Effect Guidance on Ventilators During COVID-19
- US – Ventilator Supply Mitigation Strategies – Letter to Health Care Providers
- US – Update on the Ethylene Oxide Sterilization Master File Pilot Program
- US – FDA Engagement to Mitigate Potential Shortage of Personal Protective Equipment (PPE)
Be First to Comment